Spotlight on Buprenorphine/Naloxone in the Treatment of Opioid Dependence†

Author： Orman Jennifer S.   Keating Gillian M.  

Publisher： Adis International

ISSN： 1172-7047

Source： CNS Drugs, Vol.23, Iss.10, 2009-10, pp. : 899-902

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Buprenorphine/Naloxone: A Review of its Use in the Treatment of Opioid Dependence

By Orman Jennifer S.   Keating Gillian M.  

Drugs, Vol. 69, Iss. 5, 2009-03 ,pp. : 577-607

Adis International

Access to resources Recommend Favorite

Evaluation of Buprenorphine Dosage Adequacy in Opioid Receptor Agonist Substitution Therapy for Heroin Dependence: First Use of the Buprenorphine-Naloxone Dosage Adequacy Evaluation (BUDAVA) Questionnaire

By D'Amore Antonio  

Clinical Drug Investigation, Vol. 32, Iss. 7, 2012-07 ,pp. : 427-432

Adis International

Access to resources Recommend Favorite

Pharmacokinetic Interactions between Buprenorphine/Naloxone and Raltegravir in Subjects Receiving Chronic Buprenorphine/Naloxone Treatment

By Douglas Bruce R.  

The American Journal of Drug and Alcohol Abuse, Vol. 39, Iss. 2, 2013-03 ,pp. : 80-85

Informa Healthcare

Access to resources Recommend Favorite

Buprenorphine: Clinical Pharmacokinetics in the Treatment of Opioid Dependence

By Elkader Alexander   Sproule Beth  

Clinical Pharmacokinetics, Vol. 44, Iss. 7, 2005-01 ,pp. : 661-680

Adis International

Access to resources Recommend Favorite

Less Pain, More Gain: Buprenorphine-Naloxone and Patient Retention in Treatment

By Renzelli Cara M.   Capretto Neil A.  

Journal of Addictive Diseases, Vol. 25, Iss. 3, 2006-08 ,pp. : 97-104

Haworth Press

Access to resources Recommend Favorite